Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000041

Chief Scientific Officer sold 1,238 shares at $18.00 ($22,284)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Sethuraman Natarajan Chief Scientific Officer 2024-07-12 Sale 10b5-1 −600 $18.00 $10,800 189,452 D
Sethuraman Natarajan Chief Scientific Officer 2024-07-15 Sale 10b5-1 −638 $18.00 $11,484 188,814 D
Open-market sales · 1,238 sh · avg $18.00 · $22,284
Loading xslF345X05/wk-form4_1721162618.xml…